Estragen Pharma Private Limited

Estragen Pharma Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24232RJ2009PTC028192 Incorporated 29 January 2009 ROC Jaipur HQ Jaipur, Rajasthan, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹6.8 Cr
▲ 2% YoY
Net profit · FY 2025
₹33.74 Lakh
Net margin 5%
EBITDA · FY 2025
₹66.06 Lakh
EBITDA margin 9.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹50 Lakh
No open charges
Company age
17 yrs
Est. 2009
Employees · EPFO
23
Provident fund records

About Estragen Pharma Private Limited

Data last updated:

Estragen Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2009PTC028192. Its GSTIN is 08AACCE1350L1ZQ (Rajasthan).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shyam Sunder Gurhani and Manju Gurhani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.8 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹33.74 Lakh (net margin 5%) and EBITDA of ₹66.06 Lakh (EBITDA margin 9.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.

The company has about 23 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹50 Lakh on record. Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 4 cases are pending.

Estragen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0272159). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website estragenpharma.com.

Company details

CIN U24232RJ2009PTC028192
Registration Number 028192
Incorporation Date 29 January 2009
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0272159

Recognitions & Rankings of Estragen Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-RJ-17-0272159

Contact details

Estragen Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its website is estragenpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Estragen House Plot No. 1, Ganga Sagar – A Vaishali Marg West Bajri Mandi Road, Jaipur, Rajasthan, India – 302034
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Estragen Pharma Private Limited, buy the company report.

Comprehensive company report
Estragen Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Estragen Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Estragen Pharma Private Limited, buy the company report.

Financials of Estragen Pharma Private Limited

FY 2025 filings available

Estragen Pharma Private Limited reported revenue of ₹6.8 Cr (up 2% YoY) for FY 2025.

Revenue · FY 2025
₹6.8 Cr ▲ 2%
Net profit · FY 2025
₹33.74 Lakh margin 5%
EBITDA · FY 2025
₹66.06 Lakh margin 9.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 10%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 8%
5 years · compounded
▲ 15%

Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 2% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹66.06 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹33.74 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.7%
Net Profit Margin5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Estragen Pharma Private Limited, buy the company report.

Board of directors of Estragen Pharma Private Limited

Estragen Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shyam Sunder GurhaniDirector29 Jan 200917 Years 9 MonthsCurrent
Manju GurhaniDirector29 Jan 200917 Years 9 MonthsCurrent

Peer comparison

Estragen Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Saksham Pharmaceuticals (India) Limited₹6.86 Cr (FY 2025)1.0%New Delhi, Delhi, India
Estragen Pharma Private Limitedthis company₹6.8 Cr (FY 2025)₹33.74 Lakh5%2.0%23Jaipur, Rajasthan, India
Care Tech Life Science Private Limited₹6.78 Cr (FY 2025)-14.0%Bangalore, Karnataka, India
Aingo Pharma Private Limited₹6.77 Cr (FY 2024)15.0%Manimajra, Chandigarh, India

To see the full peer comparison of Estragen Pharma Private Limited, buy the company report.

Auditor

Estragen Pharma Private Limited is audited by VINOD KUNAL & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
VINOD KUNAL & ASSOCIATESFY 2020011244C

Shareholding

The shareholding of Estragen Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Estragen Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Others₹0.30 Cr
Icici Bank Limited₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Dec 2017100154461Others₹30 LakhSatisfied
16 Dec 201310471586Icici Bank Limited₹20 LakhSatisfied

To see the full charge records of Estragen Pharma Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Estragen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Estragen Pharma Private Limited has a workforce of 23 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
23
Active EPFO establishments
1
Employee growth
21.05%

GST

Estragen Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AACCE1350L1ZQRajasthanActive01 Jul 2017

To see the full GST registrations and return filing status of Estragen Pharma Private Limited, buy the company report.

Recent activity

Estragen Pharma Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Manju Gurhani was appointed as Director on 29 Jan 2009.

AGM
Estragen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Estragen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge registered on 29 Dec 2017 via Charge ID 100154461 with Others was fully satisfied on 24 Nov 2020.
Charges
A charge registered on 16 Dec 2013 via Charge ID 10471586 with Icici Bank Limited was fully satisfied on 19 Jan 2018.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100154461 was registered on 29 Dec 2017.
Charges
A charge with Icici Bank Limited amounted to Rs. 20.00 Lakh with Charge ID 10471586 was registered on 16 Dec 2013.
Charges
A charge with Icici Bank Limited of Rs. 20.00 Lakh registered on 16 Dec 2013 with Charge ID 10471586 was modified on 16 Dec 2013.
Appointed
Manju Gurhani was appointed as Director.
Appointed
Shyam Sunder Gurhani was appointed as Director.
Incorporation
29 Jan 2009
Estragen Pharma Private Limited was registered on 29 Jan 2009 with Roc Jaipur & aged 17 years 9 months as per MCA records.

Frequently asked questions

Estragen Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2009 (17+ years old) and is registered under CIN U24232RJ2009PTC028192.

Estragen Pharma has 2 current directors:

The latest financial statements of Estragen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Estragen Pharma is 08AACCE1350L1ZQ, registered in Rajasthan.

The CIN (Corporate Identification Number) of Estragen Pharma is U24232RJ2009PTC028192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Estragen Pharma has 6 court cases on record: 3 filed by the company and 3 filed against it. 4 are pending. Most are in the district courts.

Estragen Pharma was incorporated on 29 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Estragen Pharma by revenue are Saksham Pharmaceuticals (India) Limited, Care Tech Life Science Private Limited, Aingo Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Manju Gurhani was appointed as Director on 29 Jan 2009. Shyam Sunder Gurhani was appointed as Director on 29 Jan 2009.

Yes, Estragen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0272159).

Estragen Pharma can be reached through the website estragenpharma.com. Its registered office is in Jaipur, Rajasthan, India.